{"product_id":"cleveland-clinic-29th-annual-diabetes","title":"Cleveland Clinic 29th Annual Diabetes Day 2025","description":"\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003cdiv class=\"content\"\u003e\n\u003cdiv class=\"column1 bg--transparent\"\u003e\u003cheader\u003e\n\u003cdiv class=\"region region-page-title\"\u003e\n\u003cdiv class=\"block block-core block-page-title-block\" id=\"block-sb-nine-page-title\"\u003e\n\u003ch3\u003eCleveland Clinic 29th Annual Diabetes Day 2025\u003c\/h3\u003e\n\u003cstrong\u003e+ Include: 16 videos + 20 pdfs, size: 5.35 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e+ Target Audience: endocrinologists, diabetes educators\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cp class=\"boldBlue\"\u003e\u003cstrong\u003eThe 29th Annual Diabetes Day: Therapeutics, Technology and Surgery \u003c\/strong\u003eis presented by the Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism to provide up-to-date reviews of management strategies and research on the complications of diabetes. Key topic areas that will be addressed include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eReview of therapeutic options to manage both Type 1 and 2 diabetes and their complications, including a pump update, and new insulins and continuous glucose monitoring updates.\u003c\/li\u003e\n\u003cli\u003eImportance of maintaining muscle mass during obesity management.\u003c\/li\u003e\n\u003cli\u003eLatest technology in insulin pumps\u003c\/li\u003e\n\u003cli\u003eNew roles for GLP1 receptor agonists SGLT-2 inhibitors and mineralocorticoid receptor antagonists\u003c\/li\u003e\n\u003cli\u003eComplications of GLP-1 receptor agonists\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eThis year’s curriculum will also feature discussions about:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eGlucose variability and diabetes\u003c\/li\u003e\n\u003cli\u003eEffects of high fat and high protein diets on glucose control\u003c\/li\u003e\n\u003cli\u003eEffects of GLP-1 on sleep apnea\u003c\/li\u003e\n\u003cli\u003eNutritional supplements in treatment of DM2\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe goal of this symposium is to increase practitioners’ competence and clinical performance in treating diabetes and its complications and, ultimately, to improve patient outcomes.\u003cbr\u003e\u003ch3\u003e\u003cstrong\u003eAttendees will be able to:\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eCritically appraise clinical evidence and guidelines supporting hybrid closed-loop systems in pregnancy and identify key considerations when initiating and monitoring hybrid closed-loop pumps during pregnancy.\u003c\/li\u003e\n\u003cli\u003eDescribe the efficacy of inhaled insulin to insulin pump therapy in diabetes management.\u003c\/li\u003e\n\u003cli\u003eDiscuss the role of nutritional supplements in the management of Type 2 diabetes and glycemic control, including the use of berberine.\u003c\/li\u003e\n\u003cli\u003eDiscuss future directions and challenges in developing and implementing oral GLP-1 agonists and multi-agonist therapy in diabetes care and summarize clinical evidence on the incidence and risk of gastroparesis, pancreatitis, and thyroid cancer associated with GLP-1 agonist use.\u003c\/li\u003e\n\u003cli\u003eAnalyze current research and define treatment strategies for challenges in diabetes care, including dementia, blood pressure, including intensive blood pressure control, and cardiovascular and renal complications in diabetes.\u003c\/li\u003e\n\u003cli\u003eDiscuss evidence-based treatment strategies for post-gastric bypass hypoglycemia, including dietary modifications, pharmacotherapy, and other interventions.\u003c\/li\u003e\n\u003cli\u003eDiscuss practical considerations for initiating and titrating novel therapies such as efsitora alfa in different patient populations, including those with complex diabetes management needs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cstrong\u003eWho should attend?\u003c\/strong\u003e\u003c\/h3\u003e\n\u003cbr\u003eThis activity is designed for physicians, diabetes educators, nurses, nurse practitioners, pharmacists, pharmacy technicians, physician assistants, residents and fellows, and other health care professionals who care for patients with diabetes.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003ctable border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"agenda agendaBorderColor\" id=\"day1-table\" width=\"1376\"\u003e\n\u003ctbody\u003e\n\u003ctr class=\"header\"\u003e\n\u003ctd class=\"agendaBorderColor agendaRowShade borderBottom1px\" colspan=\"2\" height=\"auto\"\u003e\n\u003ch3 class=\"white\"\u003eThursday, May 22, 2025 \u003cem class=\"agenda-alltimes\"\u003eAll times in Eastern Time\u003c\/em\u003e\n\u003c\/h3\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e7:00 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eRegistration and Exhibits\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e7:15 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eNon-CME Breakfast Session\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e7:55 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eWelcome and Introduction \u003c\/strong\u003e\u003cem\u003eRobert Zimmerman, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e8:00 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eNew Technology: Equity and Access \u003c\/strong\u003e\u003cem\u003eSarah Macleish, DO\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e8:30 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eUse of Hybrid Closed Loop Pumps in Pregnancy in DM 1 and DM 2 \u003c\/strong\u003e\u003cem\u003eKevin Borst, DO\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e8:50 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003ePreventing Type 2 Diabetes: Current Management of Pre Diabetes \u003c\/strong\u003e\u003cem\u003eOscar Morey Vargus, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e9:10 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eNutritional Supplements in Treatment of DM 2: Focus on Berberine \u003c\/strong\u003e\u003cem\u003eKeren Zhou, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e9:30 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eOral GLP-1 Receptor Agonists and Multi Agonist Therapy \u003c\/strong\u003e\u003cem\u003eRobert Zimmerman, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e10:00 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eRefreshment Break and Exhibits\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e10:15 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eIncreased Risk of Demetia in Patients with Diabetes and How to Prevent \u003c\/strong\u003e\u003cem\u003eWilly Valencia Rodrigo, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e10:35 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eEffect of Intensive BP Control in Diabetes. New insights from BP ROAD \u003c\/strong\u003e\u003cem\u003eDennis Bruemmer, MD, PhD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e11:00 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eTreatment of Post Gastric Bypass Hypoglycemia \u003c\/strong\u003e\u003cem\u003eLina Alkhaled, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e11:30 am\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eComplications of GLP-1 Receptor Agonists: Gastroparesis, Pancreatitis, Thyroid Cancer: What is the Data? \u003c\/strong\u003e\u003cem\u003eKevin Pantalone, DO\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e12:00 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eUltra Long-acting Insulins Focus on Efsitora Alpha \u003c\/strong\u003e\u003cem\u003eRavali Veeramachaneni, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e12:30 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eConcurrent Non-CME Lunch Presentations\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e1:30 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eUse of Insulin Pumps; Innovations in the Last Year \u003c\/strong\u003e\u003cem\u003eDiana Isaacs, PharmD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003ch4\u003e\u003cstrong\u003eConcurrent Workshops\u003c\/strong\u003e\u003c\/h4\u003e\n\u003cdiv class=\"ws\"\u003e\n\u003cbr\u003e\u003cbr\u003e2:05 pm \u003cstrong\u003eWorkshop 1 – CGM Workshop \u003c\/strong\u003e\u003cem\u003eCecilia Lansang, MD Kevin Malloy, DO Diana Isaacs, PharmD\u003cbr\u003e\u003c\/em\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"ws\"\u003e\n\u003cbr\u003e\u003cbr\u003e2:05 pm \u003cstrong\u003eWorkshop 2 – Diabetes Distress: Simulation and Discussion \u003c\/strong\u003e\u003cem\u003eEmily Durfey, MSW, LSW Stephanie Ash, MSW, LSW Keysha Ramsey, BSW, LSW\u003c\/em\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"ws\"\u003e\n\u003cbr\u003e\u003cbr\u003e2:05 pm \u003cstrong\u003e\u003cem\u003eWorkshop 3 – Prevention of Exercise Induced Hypoglycemia: Metoclopramide and Low Dose Glucagon \u003c\/em\u003e\u003c\/strong\u003e\u003cem\u003eMona Gossman, MD\u003c\/em\u003e\u003cbr\u003e\u003cbr\u003e2:35 pm \u003cstrong\u003eScreening for Diabetes Related Antibodies for Prevention of Type 1 Diabetes \u003c\/strong\u003e\u003cem\u003eLeann Olansky, MD\u003c\/em\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e3:05 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eRefreshment Break and Exhibits\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e3:20 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003ePreserving Muscle Mass with Weight Loss with High Protein Diet \u003c\/strong\u003e\u003cem\u003eMarcio Griebeler, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e3:45 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eImplications of Glucose Variability on Chronic Complications of Diabetes \u003c\/strong\u003e\u003cem\u003eAdi Mehta, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e4:15 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eEffect of GLP-1\/GIP Agonists on Sleep Apnea \u003c\/strong\u003e\u003cem\u003eMarwan Hamaty, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e4:45 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\n\u003cstrong\u003eMASH, NASH, NAFLD, MASLD: Who to Screen, How to Treat , When to Refer \u003c\/strong\u003e\u003cem\u003eYael Mauer, MD\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd width=\"15%\"\u003e\n\u003cdiv align=\"right\"\u003e5:15 pm\u003c\/div\u003e\n\u003c\/td\u003e\n\u003ctd valign=\"top\"\u003e\u003cstrong\u003eAdjourn\/Non-CME Reception\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954498048098,"sku":"MED-AMB04657","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Cleveland-Clinic-29th-Annual-Diabetes-Day-2025.jpg?v=1779378106","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-29th-annual-diabetes","provider":"Meducourse","version":"1.0","type":"link"}